A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
{{output}}
Dasatinib is a second-generation tyrosine kinase inhibitor with activity on the BCR-ABL fusion gene. It is used in the treatment of BCR-ABL positive chronic myeloid leukaemia and has the known side effect of pleural effusion. This usually involves exudate with... ...
